![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 42, 29666-29671, October 15, 1999
§,
,
,
,
,
,
,
**
From the
Group of Neurobiology, School of Allied
Health Sciences, Osaka University Faculty of Medicine, Yamadaoka 1-7, Suita-shi, Osaka, 565-0871, Japan, the § First Department of
Oral and Maxillo-Facial Surgery, Osaka University Faculty of Dentistry,
Yamadaoka 1-8, Suita-shi, Osaka, 565-0871, Japan, the ¶ Department
of Molecular Genetic Research, National Institute for Longevity
Sciences, Morioka-cho, Ohbu-shi, 474-5822, Japan, and the
Division of Biochemistry and Cellular Biology, National
Institute of Neuroscience, National Center of Neurology and Psychiatry,
4-1-1 Kodaira, Tokyo 187-8502, Japan
| |
ABSTRACT |
|---|
|
|
|---|
We recently showed that mouse semaphorin H (MSH),
a secreted semaphorin molecule, acts as a chemorepulsive factor on
sensory neurites. In this study, we found for the first time that MSH induces neurite outgrowth in PC12 cells in a dose-dependent
manner. Comparison of Ras-mitogen-activated protein kinase (MAPK)
signaling pathways between MSH and nerve growth factor (NGF) revealed
that these pathways are crucial for MSH action as well as NGF. K-252a, an inhibitor of tyrosine autophosphorylation of tyrosine kinase receptors (Trks), did not inhibit the action of MSH, suggesting that
MSH action occurs via a different receptor than NGF. L- and N-types of
voltage-dependent Ca2+ channel blockers,
diltiazem and Nervous system function is dependent upon highly specific
connections that form between neurons during development. The
patterning and specificity of these connections requires neurite
extension toward the proper targets guided by the growth cone in
response to environmental signals. However, the process that involves
signal-induced morphological changes resulting in coordinated
cytoskeletal remodeling in the specialized growth cone is poorly
understood (1).
The semaphorins/collapsins are a large family of structurally distinct
secreted and transmembrane proteins characterized by the presence of a
conserved sema domain of about 500 amino acids (2-4). Chick
collapsin-1 and its mammalian homolog, mouse semaphorin D
(MSD)1 (initially named sema
III), act in vitro as collapsing factors on growth cones and
as selective chemorepellents for subpopulations of spinal and cranial,
sensory, and motor axons (5, 6). Thus, semaphorins are thought to be
involved in the axon guidance mechanism during neuronal development. To
investigate the mechanism of neural network formation, we identified
several novel semaphorins (7-9). One of them, mouse semaphorin H (MSH)
is structurally similar to MSD and acts as a chemorepellent on sensory
axons (9, 10). To investigate the signaling pathway for secreted
semaphorin MSH, we used PC12 cells (a clone derived from a
pheochromocytoma tumor of the rat adrenal medulla), which are known to
differentiate into neuronal cells in response to NGF.
Studies on PC12 cells have demonstrated that a variety of extracellular
signals can lead to neurite outgrowth and morphological differentiation. In this cell line, the signaling pathway via the NGF
receptor is the most well characterized (11-13). Ligand binding to its
tyrosine kinase receptor (Trk) causes activation of
Ras-dependent MAPK cascades resulting in cellular
differentiation and neurite outgrowth (14).
In this study, we have found that MSH induces neurite outgrowth in PC12
cells through a Ras-MAPK signaling pathway similar to NGF. It has been
described that the conventional extracellular Ca2+
concentration (1 mM) is required for chemoattractive growth
cone action, induced by brain-derived neurotrophic factor,
acetylcholine, and bradykinin, and also for chemorepulsive action
induced by soluble fraction of myelin-associated glycoprotein (15, 16). In this study, we investigated whether Ca2+ influx is
involved in MSH-induced PC12 cell neurite outgrowth.
MSD acts as a chemorepellent on sensory and sympathetic axons via
neuropilin-1 receptor (17, 18). Antibodies against the extracellular
domain of neuropilin-1 block the effects of MSD in vitro.
However, the chemorepulsive action of MSD can be converted to
chemoattraction by membrane-permeable cyclic GMP agonists via the same
neuropilin-1 receptor (15). These findings show that different actions,
for instance growth cone attraction and repulsion, can occur via the
same receptor. We examined the involvement of neuropilins in MSH action
on PC12 cells. In this study, we describe the neurite outgrowth effect
of MSH on PC12 cells and the signaling pathways that this action occurs through.
Materials--
NGF (7S) was purchased from Roche Molecular
Biochemicals. PD98059 was purchased from Research Biochemicals
International (Natick, MA). K-252a and Gö6983 were purchased from
CALBIOCHEM (La Jolla, CA). Calphostin C was purchased from Wako (Osaka,
Japan). Diltiazem was purchased from Life Technologies, Inc.
Cell Culture--
PC12 cells, NIH3T3 cells, and 293T cells were
cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented
with 0.35% glucose, 10% fetal bovine serum, and 100 units/ml
penicillin. All cells were grown at 37 °C in 5%
CO2.
Preparation of MSH-AP, MSE-AP, AP, and MSD--
The conditioned
media containing MSH-AP, mouse semaphorin E (MSE)-AP, AP or MSD were
obtained from NIH3T3 cells and/or 293T cells expressing them and
concentrated with Centricon (Amicon) as described previously (9, 10).
The concentration of the proteins was determined from AP activity
assayed at 405 nm, and AP activity was equalized in MSH-AP and AP
(19).
Determination of Neurite Outgrowth--
PC12 cells were
dissociated in phosphate-buffered saline solution followed by
incubation at 37 °C for ~2 min with 0.05% (w/v) trypsin in the
same buffer. A single-cell suspension was obtained by trituration of
pelleted trypsinized cells, resuspended in DMEM. For culture
experiments, 2 × 104 cells or 5 × 103 cells were added to each well of a 24-well plate
(Costar) or 48-well plate (Costar) that had been coated with
poly-L-lysine. After plating for 1 h, cells were
treated with various reagents (PD98059, K-252a, Gö6983,
calphostin C, diltiazem, or
To determine whether MSH-AP action is specific to MSH-AP, the
conditioned media containing MSH-AP or AP were absorbed with anti-AP
mouse antibody or normal mouse IgG (control) immobilized on beads at
4 °C for 1 h. After removal of beads, the resulting conditioned
media were assayed for neurite outgrowth as described above.
Detection of Activated p44/42 MAPK--
To detect phospho-MAPK
proteins stimulated by NGF, AP, or MSH-AP, PC12 cells (2 × 105/60-mm dish) were treated with 50 ng/ml NGF, 1 nM AP, or 1 nM MSH-AP at 37 °C for the
duration indicated in the text. Cells were lysed in lysis buffer (20 mM Tris, pH 7.6, 1 mM EDTA, 150 mM
NaCl, 1% Triton X-100, 1 mM
Na3VO4, 50 mM NaF, 1 mM
phenylmethylsulfonyl fluoride, 10 mg/ml pepstatin). Aliquots of the
lysates (10-15 µg) from each sample were fractionated on SDS-10%
polyacrylamide gel and transferred to polyvinylidene difluoride
membranes (0.45-µm pore size Immobilon-P, Millipore). The blots were
probed with the phospho-p44/42 MAPK antibody (PhosphoPlus p44/42 MAPK
antibody kit, New England BioLabs) at a dilution of 1:1000 in blocking buffer (10 mg/ml bovine serum albumin) for 60 min at room temperature. The blots were probed with secondary antibody, horseradish
peroxidase-linked anti-rabbit IgG, at a dilution of 1:2000 in blocking
buffer for 60 min at room temperature. The blots were stained for 1 min
using the nucleic acid chemiluminescence reagent (LumiGLO
chemiluminescent reagent, Kirkegaard and Perry Laboratories) and
exposed to x-ray film. Blots were stripped with 62.5 mM
Tris, pH 6.7, 2% SDS, and 100 mM Monitoring of Intracellular Ca2+ Levels--
For
monitoring intracellular Ca2+ levels, cells were loaded by
exposing them to 10 µM (final concentration) Fura 2-AM
(Molecular Probes) in the dark at 37 °C for 60 min (22). Cultures
were then rinsed and perfused continuously in a modified Kreb's
solution containing 115 mM NaCl, 5.4 mM KCl,
0.8 mM MgCl2, 1.8 mM
CaCl2, 13.8 mM D-glucose, and 20 mM HEPES, pH 7.4. Fluorescence measurements calculated with
a real time image processor, ARGUS-50/CA (Hamamatsu Photonics KK), were
shown as 340/380 nm (excitation) ratios obtained from groups of six
cells. Measurements shown are representative of at least three and, in
most cases, a larger number of independent experiments.
MSH Induces Neurite Outgrowth in PC12 Cells--
PC12 cells were
incubated with 1 nM MSH-AP, 50 ng/ml NGF, 1 nM
AP, MSD, or 1 nM MSE-AP for 24 h. The majority of PC12
cells cultured with AP, MSD, or MSE-AP showed no neurite growth (Fig. 1A). In contrast, many PC12
cells showed morphological differentiation in response to MSH-AP or
NGF. The percentages of morphologically differentiated cells are
summarized (Fig. 1B). MSH-AP induced neurite outgrowth in
85.3 ± 4.7% of PC12 cells, compared with 80.7 ± 3.2, 9.8 ± 2.3, 5.9 ± 2.0, and 6.1 ± 2.6% in the media containing NGF, MSE-AP, MSD, and AP, respectively. When the medium containing MSH-AP was preincubated with anti-AP antibodies, the neurite
outgrowth activity was dramatically reduced, whereas the activity of
NGF was unaffected (Fig. 1C). The dose-dependent
action of MSH-AP was investigated next. MSH-AP induced neurite
outgrowth in PC12 cells in a dose-dependent manner (Fig.
1D). The percentage of differentiated cells reached about
100% at 2 nM MSH-AP. AP as control did not induce neurite
outgrowth in the same concentration range. These findings suggest that
MSH, but not AP, induces neurite outgrowth in PC12 cells, dependent on
its specific binding to them.
Neurite Outgrowth Actions of MSH and NGF Mediated by Ras-MAPK
Signal Transduction via Distinct Receptor--
Because it has been
suggested that NGF-induced sustained activation of the MAPK pathway is
crucial to the neuronal differentiation of PC12 cells (14), we
investigated whether MSH induces neurite outgrowth via sustained
activation of the MAPK pathway. MAPK kinase/MEK inhibitor PD98059 was
used to block MAPK activation (23). PD98059 markedly inhibited neurite
outgrowth activity of NGF in a dose-dependent manner,
supporting previous findings (Fig.
2A). MSH-induced neurite outgrowth was also inhibited by PD98059 in a similar
dose-dependent manner, suggesting that the activation of
the MAPK pathway is critical to the neurite outgrowth activity of MSH.
We then used immunoblot analysis with anti-phospho-p44/p42 MAPK
antibody to detect activated MAPK in PC12 cells stimulated by NGF or
MSH-AP. 1 nM MSH-AP induced an increase in MAPK1/2
activation in PC12 cells within 2 min (Fig. 2B). This
activation reached peak level after 5 min and lasted at least 60 min.
NGF similarly stimulated sustained activation of MAPK in PC12 cells as
described previously (14) (Fig. 2B), whereas AP did not
cause any significant activation of MAPK. These findings suggest that
sustained activation of MAPK is crucial for MSH-induced neurite
outgrowth of PC12 cells as well as NGF.
Ras activation is upstream of the MAPK pathway in NGF-induced neurite
outgrowth of PC12 cells. Thus, we investigated whether Ras regulation
is involved in the signal transduction of MSH-induced neurite outgrowth
of PC12 cells. Dominant-negative Ras overexpressing PC12 cells (PC12Ha
RHK cells) and mock cells (PC12Ha XMV cells) were incubated with MSH-AP
or NGF. Overexpression of dominant-negative Ras almost completely
inhibited MSH-AP induced neurite outgrowth as well as NGF-induced
neurite outgrowth, whereas the majority of mock PC12Ha XMV cells showed
morphological differentiation in response to MSH-AP as well as NGF
(Fig. 3). These findings suggest that Ras
activation is necessary for MSH-induced neurite outgrowth in analogy
with NGF. Activation of the Ras-MAPK cascade may therefore be essential
for neurite outgrowth activity induced by MSH.
To investigate whether Trks and their signal transduction are involved
in MSH-induced neurite outgrowth, K-252a was used to block tyrosine
autophosphorylation of Trks and their downstream signal transduction
(24, 25). PC12 cells were incubated with the indicated concentration of
K-252a for 15 min prior to MSH-AP addition (Fig.
4). K-252a at 100 nM markedly
inhibited NGF-induced neurite outgrowth but did not exert any
inhibition on MSH-AP induced neurite outgrowth, suggesting that the
neurite outgrowth action of MSH is not mediated by Trks. Thus, MSH and
NGF actions are mediated by distinct upstream receptors sharing a
common signaling pathway via Ras-MAPK cascades.
Protein Kinase C Inhibitors Reduce Neurite Outgrowth Activity of
MSH and NGF--
Because activation of PKC stimulates NGF-induced
neuronal differentiation of PC12 cells (26, 27), we investigated the involvement of PKC in the signal transduction of MSH-induced neurite outgrowth. PC12 cells were treated with a PKC inhibitor, calphostin C
(20) or Gö6983 (28), for 30 min prior to addition of MSH-AP or
NGF. Both treatments blocked MSH-AP action as well as NGF action (data
not shown). 20 nM calphostin C markedly inhibited neurite outgrowth induced by MSH-AP and NGF; 50 nM Gö6983
showed similar inhibition. These data suggest that PC12 cell neurite
outgrowth induced by MSH and NGF is dependent on PKC activation.
Ca2+ Influx Is Required for Action of MSH, but Not for
NGF--
By culturing PC12 cells in 25 mM KCl and 100 nM BayK8644, it has been reported that
depolarization-induced neurite growth requires Ca2+ entry
via voltage-dependent Ca2+ channels (29). To
determine whether Ca2+ influx is crucial for MSH-induced
neurite outgrowth, two types of Ca2+ channel blockers,
diltiazem, an L-type Ca2+ channel blocker, and
To determine whether extracellular Ca2+ influx is induced
in response to MSH-AP stimulation, fluorescent ratios of F340/F380 were
measured to indicate intracellular Ca2+ levels by a real
time image processor using Fura 2-AM following MSH-AP stimulation. The
addition of KCl, a postitive control, caused a quick and transient
increase in Ca2+ levels (Fig.
6A). Ca2+ levels
also transiently increased 1-2 min after adding MSH-AP (Fig.
6B), whereas Ca2+ levels did not increase after
adding AP (Fig. 6C). These findings indicate that
extracellular Ca2+ influx in the early stage of the
signaling pathway trigers MSH action on PC12 cells.
Is MSH Action on PC12 Cells Mediated by Neuropilin
Receptors?--
To investigate whether MSH action on PC12 cells occurs
via neuropilin-1, neutralizing neuropilin-1 antibodies for the
extracellular domain of neuropilin-1 were used. Neuropilin-1
neutralizing antibodies, which blocked MSH collapsing action on sensory
growth cones, did not inhibit MSH action on PC12 cells (data not
shown). We also used a large excess of MSE to compete with MSH for
binding to neuropilins, because MSE have no effect on PC12 cells but
binds to both neuropilin-1 and 2 (31) (data not shown). A 40-fold concentration of MSE did not inhibit the action of MSH on PC12 cells
(data not shown), suggesting that MSH probably acts on PC12 cells
through unknown receptor distinct from neuropilins.
In the present study we have shown that MSH can induce neurite
outgrowth of PC12 cells in a dose-dependent manner. Nearly all cells showed morphological differentiation with long neurites in
response to MSH. This morphological differentiation appeared to be
similar to that by NGF. Then we analyzed the cytoplasmic signaling
pathway of MSH action comparing with that of NGF action. The major
finding obtained about the signal pathway of the action of MSH can be
summarized as follows: (a) MSH-induced neurite outgrowth of
PC12 cells was mediated by the sustained activation of MAPK in a
similar fashion for NGF. (b) Ras activation was also
critical to MSH-induced morphological differentiation of PC12 cells.
(c) MSH-induced signaling pathway was independent on the
activation of Trks which has been known as NGF receptors (Fig. 4).
(d) MSH- but not NGF-induced morphological differentiation
of the cells were blocked by two types of calcium blockers.
(e) MSH- but not NGF-induced MAPK activation was inhibited
by deprivation of extracellular Ca2+. (f) MSH
induced a transient Ca2+ influx of PC12 cells. These
results imply that the Ras-MAPK signaling pathway was shared between
MSH and NGF, but the upstream signaling is apparently distinct between
the two ligands.
So far several studies have reported that Ca2+ influx links
extracellular signals to Ras-MAPK signaling pathway (29, 32-36). In
some cases, Ca2+ influx activates Pyk2 and c-Src and
results in activation of Shc (SH2/collagen protein) and MAPK (29, 37,
38). In other cases, increase of intracellular Ca2+
activates several Ras guanylnucleotide-exchange factor (Ras-GEF) molecules, Ras-GRF1 (32, 33), and RasGRP/rbc7 (36) and result in
activation of Ras-MAPK signaling system. This study indicates that
Ca2+ influx is necessary for MSH-induced neurite outgrowth
of PC12 cells independently of Trk tyrosine kinase receptors. Thus, it is probable that binding of MSH to its receptor appears to cause Ca2+ influx via voltage-dependent
Ca2+ channels followed by activation of Ras-MAPK cascades
to induce neurite outgrowth in PC12 cells, although it is unknown what
the receptor is for MSH and what links Ca2+ influx to
Ras-MAPK. A lag in Ca2+ increase of about 1 min after
adding MSH-AP may suggest that any chemical reactions such as
phosphorylation reactions are involved in the upstream of
Ca2+ and Ras-MAPK signaling cascades of MSH action. Such a
lag in Ca2+ level of about 1 min has been also shown when
PC12 cells were stimulated with NGF (39), of which signaling includes
tyrosine and serine/threonin phosphorylations (11-13, 26). Our
findings using PKC inhibitors suggest that PKC activation is also
involved in MSH-induced neurite outgrowth in PC12 cells as well as
NGF-induced neurite outgrowth (26). This result supports a significant
relationship between MSH signaling and Ca2+ influx.
Recently, it has been reported that neuropilins are receptors for
secreted semaphorin molecules. MSD acts as a chemorepellent on sensory
and sympathetic axons via neuropilin-1 receptor, and MSE similarly acts
as a chemorepellent on sympathetic axons via neuropilin-2 receptor
(31). We recently showed that MSH also acted as a chemorepellent on
sensory axons via neuropilin-1 receptors (9). Song and colleagues (15)
have reported that cGMP analogues could convert the repulsive action of
MSD to attractive via neuropilin-1 receptor. Therefore, MSH can act as
a chemoattractant via neuropilin-1 receptors on PC12 cells. The action
of MSH may depend on cell types or cell states modulated by second
messengers such as cyclic nucleotides. Otherwise, MSH-induced neurite
outgrowth occurs via an unknown receptor that is distinct from
neuropilins. This hypothesis is supported by the following results:
(a) Neutralizing neuropilin-1 antibodies did not inhibit MSH
action on PC12 cells. (b) A large excess of MSE, a
competitive ligand for neuropilins (31), did not inhibit MSH-induced
neurite outgrowing action. However, these observations do not
exclusively rule out a possibility that MSH action on PC12 cells is
mediated by neuropilins, because these do not completely refute the
possibility that MSE and MSH would bind separate domains of
neuropilins. On the other hand, it has been reported that
chemorepellent activity of MSD, which is known to act via neuropilin-1
receptor, is independent on extracellular Ca2+ level (15,
40). Our results showing the dependence of MSH-mediated signaling on
extracellular Ca2+ concentration may support the idea
that MSH-induced neurite outgrowth of PC12 cells is signaled via a
receptor separate from neuropilins. The present study indicates a
possible physiological role for MSH in effecting changes in cell
phenotype through cell-cell interactions.
-conotoxin, inhibited MSH-induced neurite outgrowth
and MAPK phosphorylation in a Ca2+-dependent
manner. A transient elevation in intracellular Ca2+ level
was observed upon MSH stimulation. These findings suggest that
extracellular Ca2+ influx, followed by activation of the
Ras-MAPK signaling pathway, is required for MSH induced PC12 cell
neurite outgrowth.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Conotoxin GVIA was purchased from Alomone Labs (Jerusalem, Israel).
All reagents were used at concentrations established in literature to
substantially block their respective targets. Other materials used in
this study were described previously (9, 10).
-conotoxin GVIA) at the indicated
concentrations. To activate calphostin C, the cells were irradiated
with a cool white fluorescent lamp located 20 cm away for preincubation
(20). PC12 cell differentiation was determined by scoring for neurite
length. Cells possessing one or more neurites of a length greater than
1.5-fold the diameter of the cell body were scored as positive (21).
Each value is the mean ± S.E. for 100-150 PC12 cells sampled
from three independent experiments.
-mercaptoethanol at
50 °C for 30 min and reprobed with p44/42 MAPK antibody to verify
that the protein levels were uniform.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (41K):
[in a new window]
Fig. 1.
Induction of neurite outgrowth by MSH.
A, PC12 cells (approximately 2 × 104
cells/ml) were cultured in DMEM containing 1 nM MSH-AP, 50 ng/ml NGF, 1 nM AP or MSD for 24 h. Bar, 50 µm. B, PC12 cells (approximately 2 × 104
cells/ml) were cultured in DMEM containing 1 nM AP, 1 nM MSH-AP, 50 ng/ml NGF, 1 nM MSE-AP or MSD.
The percentage of cells with neurites was determined after 24 h.
Each value is the mean ± S.E. for 100-150 PC12 cells sampled
from three independent experiments. *, p < 0.001, by
Student's t test. C, sensitivity of the action
of MSH-AP to pretreatment with anti-AP antibody. DMEM containing AP,
MSH-AP, or NGF was pretreated with an anti-AP antibody
(anti-AP) or mouse IgG (control) immobilized on
beads. The percentage of cells with neurites was determined after
24 h. Each value is the mean ± S.E. for 100-150 PC12 cells
sampled from three independent experiments. **, p < 0.002, by Student's t test. D,
dose-dependent curve showing neurite outgrowth activity of
MSH-AP. PC12 cells (approximately 2 × 104 cells/ml)
were cultured in DMEM containing the indicated concentration of
MSH-AP or AP for 24 h. The percentage of cells with neurites is
plotted against the concentration of MSH-AP or AP. Each value is the
mean ± S.E. for 100-150 PC12 cells sampled from three
independent experiments. *, p < 0.001; **,
p < 0.002; ***, p < 0.01, respectively by Student's t test.

View larger version (25K):
[in a new window]
Fig. 2.
Activation of p42/44 MAPK by MSH.
A, effect of PD98059 on neurite outgrowth induced by MSH.
PC12 cells (approximately 2 × 104 cells/ml) were
preincubated in DMEM containing the indicated concentration of PD98059
for 15 min, and 1 nM MSH-AP or 50 ng/ml NGF was added,
followed by further incubation for 24 h. The percentage of cells
with neurites was determined after 24 h. Each value is the
mean ± S.E. for 100-150 PC12 cells sampled from three
independent experiments. B, time course of MAPK
phosphorylation in PC12 cells stimulated by MSH. PC12 cells
(approximately 5 × 105 cells/ml) were treated with
DMEM containing 1 nM AP, 1 nM MSH-AP or 50 ng/ml NGF. At the indicated time, the cells were lysed, and the lysates
were subjected to SDS-polyacrylamide gel electrophoresis followed by
Western blot analysis with an anti-phospho-MAPK antibody
(p-MAPK). Blots were stripped and reprobed with anti-MAPK
antibody (MAPK) to verify that the protein levels were
uniform.

View larger version (51K):
[in a new window]
Fig. 3.
Ras in MSH regulation of neurite
outgrowth. A, two PC12 cell sublines (approximately
2 × 104 cells/ml), PC12Ha XMV and PC12Ha RHK, mock
and expressing dominant-negative Ras, respectively, were cultured in
DMEM containing 1 nM MSH-AP or 50 ng/ml NGF for 24 h.
Bar, 50 µm. B, PC12Ha XMV and PC12Ha RHK
(approximately 2 × 104 cells/ml) were cultured in
DMEM containing 1 nM MSH-AP or 50 ng/ml NGF for 24 h.
The percentage of cells with neurites was determined. Each value is the
mean ± S.E. for 100-150 PC12 cells sampled from three
independent experiments. *, p < 0.001, respectively by
Student's t test.

View larger version (19K):
[in a new window]
Fig. 4.
Effect of K-252a on PC12 cell neurite
outgrowth induced by MSH. PC12 cells (approximately 2 × 104 cells/ml) were preincubated in DMEM containing the
indicated concentration of K-252a for 15 min, and 1 nM
MSH-AP or 50 ng/ml NGF was added, followed by further incubation for
24 h. The percentage of cells with neurites was determined. Each
value is the mean ± S.E. for 100-150 PC12 cells sampled from
three independent experiments. *, p < 0.001; **,
p < 0.002, respectively by Student's t
test.
-conotoxin, an N-type Ca2+ blocker, were used (30). Both
Ca2+ channel blockers, 100 µM diltiazem (Fig.
5A) and 1 µM
-conotoxin (Fig. 5B), strongly inhibited PC12 cell
neurite outgrowth induced by MSH-AP but did not have any obvious
effects on NGF-induced neurite outgrowth. These findings suggest that
Ca2+ influx via N- and L-type Ca2+ channels is
involved in the signal transduction of MSH-induced neurite outgrowth
but not NGF. We next tested whether deprivation of extracellular
Ca2+ affects MAPK activation induced by MSH-AP or NGF (Fig.
5C). MSH-AP-induced MAPK activation was markedly inhibited
by EGTA treatment, whereas NGF-induced activity was not affected,
suggesting that 1 mM extracellular Ca2+ is
required for MSH-AP-induced activation of MAPK but not for NGF.

View larger version (23K):
[in a new window]
Fig. 5.
Involvement of extracellular Ca2+
influx in MSH regulation of neurite outgrowth and effects of
Ca2+ channel blockers on PC12 cell neurite outgrowth
induced by MSH. PC12 cells (approximately 2 × 104 cells/ml) were preincubated in DMEM containing the
indicated concentration of diltiazem (A) and
-conotoxin
(B) for 15 min, and 1 nM MSH-AP or 50 ng/ml NGF
were added, followed by further incubation for 24 h. The
percentage of cells with neurites was determined. Each value is the
mean ± S.E. for 100-150 PC12 cells sampled from three
independent experiments. *, p < 0.001; **,
p < 0.002; ***, p < 0.01, respectively by Student's t test. C, effect of
removing extracellular Ca2+ on MAPK phosphorylation
stimulated by MSH. PC12 cells (approximately 5 × 105
cells/ml) were preincubated in DMEM containing the indicated
concentration of EGTA for 2 min, and 50 ng/ml NGF, 1 nM
MSH-AP, 1 nM AP or control (DMEM) was added. After 5 min,
the cells were lysed, and the lysates were subjected to
SDS-polyacrylamide gel electrophoresis followed by Western blot
analysis with anti-phospho-MAPK antibody (p-MAPK) or
anti-MAPK antibody (MAPK), as described in Fig. 2
(B).

View larger version (15K):
[in a new window]
Fig. 6.
Extracellular Ca2+ influx into
PC12 cells activated by MSH-AP. Cytosolic Ca2+ was
measured in Fura-2-loaded PC12 cells plated to glass coverslips. 100 mM KCl (A), 1 nM MSH-AP
(B), and 1 nM AP (C) were added at
the times indicated by the arrows.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. J. G. Flanagan for the AP-vectors, Dr. M. Tessier-Lavigne for the antibodies to neuropilin-1, and vectors of neuropilins and semaphorin D, and Dr. M. Tohyama and Dr. F. Murakami for encouraging us.
| |
FOOTNOTES |
|---|
* This work was partially supported by Grant-in-aid for International Scientific Research 08044282 and Grant-in-aid for Exploratory Research 10877058 (to S. I.) and Grant-in-aid for Encouragement of Young Scientists 097713529 (to T. F.) from the Ministry of Education Science and Culture.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Group of Neurobiology, School of Allied Health Sciences, Osaka University Faculty of Medicine, Yamadaoka 1-7, Suita-shi, Osaka, 565-0871, Japan. Tel.: 81-6-6879-2581; Fax: 81-6-6879-2629; E-mail: inagaki@sahs.med. osaka-u.ac.jp.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: MSD, mouse semaphorin D; MSH, mouse semaphorin H; MSE, mouse semaphorin E; NGF, nerve growth factor; AP, alkaline phosphatase; MAPK, mitogen-activated protein kinase; Trk, tyrosine kinase receptor; PKC, protein kinase C; DMEM, Dulbecco's modified Eagle's medium.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bentley, D., and O'Connor, T. P. (1994) Curr. Opin. Neurobiol. 4, 43-48[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Tessier-Lavigne, M.,
and Goodman, C. S.
(1996)
Science
274,
1123-1133 |
| 3. | Luo, Y., Raible, D., and Raper, J. A. (1993) Cell 75, 217-227[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Kolodkin, A. L, Matthes, D. J., and Goodman, C. S. (1993) Cell 75, 1389-1399[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Kobayashi, H.,
Koppel, A. M.,
Luo, Y.,
and Raper, J. A.
(1997)
J. Neurosci.
17,
8339-8352 |
| 6. | Varela-Echavarria, A., Tucker, A., Püschel, A. W., and Guthrie, S. (1997) Neuron 18, 193-207[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Inagaki, S., Furuyama, T., and Iwahashi, Y. (1995) FEBS Lett. 370, 269-272[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Furuyama, T.,
Inagaki, S.,
Kosugi, A.,
Noda, S.,
Saitoh, S.,
Ogata, M.,
Iwahashi, Y.,
Miyazaki, N.,
Hamaoka, T.,
and Tohyama, M.
(1996)
J. Biol. Chem.
271,
33376-33381 |
| 9. | Miyazaki, N., Furuyama, T., Sakai, T., Fujioka, S., Mori, T., Ohoka, Y., Takeda, N., Kubo, T., and Inagaki, S. (1999) Neuroscience 93, 401-408[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Miyazaki, N., Furuyama, T., Amasaki, M., Sugimoto, H., Sakai, T., Takeda, N., Kubo, T., and Inagaki, S. (1999) Neurosci. Res. 33, 269-274[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Thomas, S. M., DeMarco, M., D'Arcangelo, G., Halegoua, S., and Brugge, J. S. (1992) Cell 68, 1031-1040[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Jing, S., Tapley, P., and Barbacid, M. (1992) Neuron 9, 1067-1079[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Rovelli, G.,
Heller, R. A.,
Canossa, M.,
and Shooter, E. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
8717-8721 |
| 14. | Fukuda, M., Gotoh, Y., Tachibana, T., Dell, K., Hattori, S., Yoneda, Y., and Nishida, E. (1995) Oncogene 11, 239-244[Medline] [Order article via Infotrieve] |
| 15. |
Song, H.,
Ming, G.,
He, Z.,
Lehmann, M.,
Tessier-Lavigne, M.,
and Poo, M.
(1998)
Science
281,
1515-1518 |
| 16. | Graness, A., Adomeit, A., Ludwig, B., Muller, W. D., Kaufmann, R., and Liebmann, C. (1997) Biochem. J. 327, 147-154 |
| 17. | He, Z., and Tessier-Lavigne, M. (1997) Cell 90, 739-751[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y. T., Giger, R. J., and Ginty, D. D. (1997) Cell 90, 753-762[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Berger, J., Hauber, J., Hauber, R., Geiger, R., and Cullen, B. R. (1988) Gene (Amst.) 66, 1-10[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Alonso, M., Muniz, M., Hall, C., Velasco, A., and Hidalgo, J. (1998) Eur. J. Cell Biol. 76, 93-101[Medline] [Order article via Infotrieve] |
| 21. |
Morooka, T.,
and Nishida, E.
(1998)
J. Biol. Chem.
273,
24285-24288 |
| 22. | Dyer, D., Tigyi, G., and Miledi, R. (1992) Brain Res. Mol. Brain Res. 14, 302-309[Medline] [Order article via Infotrieve] |
| 23. | Alessi, D. R., Gomez, N., Moorhead, G., Lewis, T., Keyse, S. M., and Cohen, P. (1995) Curr. Biol. 5, 283-295[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Hashimoto, S.
(1988)
J. Cell Biol.
107,
1531-1539 |
| 25. |
Kruttgen, A.,
Moller, J. C.,
Heymach, J. J.,
and Shooter, E. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9614-9619 |
| 26. | Burry, R. W. (1998) J. Neurosci. Res. 53, 214-222[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Kahle, P., Mangold, M., Kuwahara, T., Schubenel, R., and Hertel, C. (1994) J. Neurochem. 62, 479-488[Medline] [Order article via Infotrieve] |
| 28. | Douglas, D. N., Fink, H. S., Ridgway, N. D., Cook, H. W., and Byers, D. M. (1999) Biochim. Biophys. Acta 1448, 439-449[Medline] [Order article via Infotrieve] |
| 29. | Rusanescu, G., Qi, H., Thomas, S. M., Brugge, J. S., and Halegoua, S. (1995) Neuron 15, 1415-1425[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Doherty, P., Ashton, S. V., Moore, S. E., and Walsh, F. S. (1991) Cell 67, 21-33[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Chen, H., Chedotal, A., He, Z., Goodman, C. S., and Tessier-Lavigne, M. (1997) Neuron 19, 547-559[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Shou, C., Farnsworth, C. L., Neel, B. G., and Feig, L. A. (1992) Nature 358, 351-354[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Farnsworth, C. L., Freshney, N. W., Rosen, L. B., Ghosh, A., Greenberg, M. E., and Feig, L. A. (1995) Nature 376, 524-527[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Rosen, L. B.,
and Greenberg, M. E.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1113-1118 |
| 35. |
McLeod, S. J.,
Ingham, R. J.,
Bos, J. L.,
Kurosaki, T.,
and Gold, M. R.
(1998)
J. Biol. Chem.
273,
29218-29223 |
| 36. |
Ebinu, J. O.,
Bottorff, D. A.,
Chan, E. Y. W.,
Stang, S. L.,
Dunn, R. J.,
and Stone, J. C.
(1998)
Science
280,
1082-1086 |
| 37. | Dikic, I., Tokiwa, G., Lev, S., Courtneidge, S. A., and Schlessinger, J. (1996) Nature 383, 547-550[CrossRef][Medline] [Order article via Infotrieve] |
| 38. |
Swanson, K. D.,
Reigh, C.,
and Landreth, G. E.
(1998)
J. Biol. Chem.
273,
19965-19971 |
| 39. | Jackson, T. R., Blader, I. J., Hammonfd-Odie, L. R., Burga, A. R., Cooke, F., Hawkins, P. T., Wolf, A. G., Katherine, A. H., and Theibert, A. B. (1996) J. Cell Sci. 109, 289-300[Abstract] |
| 40. | Ivins, J. K., Raper, J. A., and Pittman, R. N. (1991) J. Neurosci. 11, 1597-1608[Abstract] |
This article has been cited by other articles:
![]() |
A. H. Conrad, J. M. Strafuss, M. D. Wittman, S. Conway, and G. W. Conrad Thyroxine Increases the Rate but Does Not Alter the Pattern of Innervation during Embryonic Chick Corneal Development Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 139 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sato-Maeda, H. Tawarayama, M. Obinata, J. Y. Kuwada, and W. Shoji Sema3a1 guides spinal motor axons in a cell- and stage-specific manner in zebrafish Development, March 1, 2006; 133(5): 937 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Barberis, A. Casazza, R. Sordella, S. Corso, S. Artigiani, J. Settleman, P. M. Comoglio, and L. Tamagnone p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling J. Cell Sci., October 15, 2005; 118(20): 4689 - 4700. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Christensen, N. Ambartsumian, G. Gilestro, B. Thomsen, P. Comoglio, L. Tamagnone, P. Guldberg, and E. Lukanidin Proteolytic Processing Converts the Repelling Signal Sema3E into an Inducer of Invasive Growth and Lung Metastasis Cancer Res., July 15, 2005; 65(14): 6167 - 6177. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamada, Y. Ohoka, M. Kogo, and S. Inagaki Physical and Functional Interactions of the Lysophosphatidic Acid Receptors with PDZ Domain-containing Rho Guanine Nucleotide Exchange Factors (RhoGEFs) J. Biol. Chem., May 13, 2005; 280(19): 19358 - 19363. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Masuda, T. Furuyama, M. Takahara, S. Fujioka, H. Kurinami, and S. Inagaki Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones Genes Cells, September 1, 2004; 9(9): 821 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qiu, B. T. Hyman, and G. W. Rebeck Apolipoprotein E Receptors Mediate Neurite Outgrowth through Activation of p44/42 Mitogen-activated Protein Kinase in Primary Neurons J. Biol. Chem., August 13, 2004; 279(33): 34948 - 34956. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Schwamborn, R. Fiore, D. Bagnard, J. Kappler, C. Kaltschmidt, and A. W. Puschel Semaphorin 3A Stimulates Neurite Extension and Regulates Gene Expression in PC12 Cells J. Biol. Chem., July 23, 2004; 279(30): 30923 - 30926. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Wood, V. D. Sarapura, J. M. Dowding, W. W. Woodmansee, D. J. Haakinson, D. F. Gordon, and E. C. Ridgway Early Gene Expression Changes Preceding Thyroid Hormone-Induced Involution of a Thyrotrope Tumor Endocrinology, February 1, 2002; 143(2): 347 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Turquier, L. Yon, L. Grumolato, D. Alexandre, A. Fournier, H. Vaudry, and Y. Anouar Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Secretoneurin Release and Secretogranin II Gene Transcription in Bovine Adrenochromaffin Cells through Multiple Signaling Pathways and Increased Binding of Pre-Existing Activator Protein-1-Like Transcription Factors Mol. Pharmacol., July 1, 2001; 60(1): 42 - 52. [Abstract] [Full Text] |
||||
![]() |
S. Inagaki, Y. Ohoka, H. Sugimoto, S. Fujioka, M. Amazaki, H. Kurinami, N. Miyazaki, M. Tohyama, and T. Furuyama Sema4C, a Transmembrane Semaphorin, Interacts with a Post-synaptic Density Protein, PSD-95 J. Biol. Chem., March 16, 2001; 276(12): 9174 - 9181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsuji, O. Inanami, and M. Kuwabara Induction of Neurite Outgrowth in PC12 Cells by alpha -Phenyl-N-tert-butylnitron through Activation of Protein Kinase C and the Ras-Extracellular Signal-regulated Kinase Pathway J. Biol. Chem., August 24, 2001; 276(35): 32779 - 32785. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |